PVG Asset Management Corp Buys New Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

PVG Asset Management Corp bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 650 shares of the biotechnology company's stock, valued at approximately $386,000. Axon Enterprise makes up approximately 1.8% of PVG Asset Management Corp's portfolio, making the stock its 24th biggest position.

Other hedge funds have also modified their holdings of the company. Fourth Dimension Wealth LLC purchased a new stake in shares of Axon Enterprise during the 4th quarter worth about $30,000. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $40,000. Y.D. More Investments Ltd acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $45,000. Elequin Capital LP acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $46,000. Finally, Stonebridge Financial Group LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth about $53,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total value of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at $1,657,583,622.18. This represents a 0.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares of the company's stock, valued at $899,275.44. This trade represents a 15.87% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 34,969 shares of company stock valued at $23,127,314 in the last 90 days. Company insiders own 5.70% of the company's stock.

Axon Enterprise Price Performance

AXON stock traded up $4.92 during mid-day trading on Wednesday, reaching $751.00. The company's stock had a trading volume of 524,465 shares, compared to its average volume of 739,108. The stock has a market cap of $58.47 billion, a PE ratio of 194.06, a P/E/G ratio of 5.17 and a beta of 1.24. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $755.05. The company's 50 day moving average is $610.27 and its two-hundred day moving average is $607.70.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to analysts' expectations of $585.67 million. During the same quarter in the prior year, the company posted $1.15 EPS. The business's revenue for the quarter was up 31.3% on a year-over-year basis. Equities research analysts expect that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on AXON shares. Barclays upped their price target on shares of Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. Needham & Company LLC upped their price target on shares of Axon Enterprise from $600.00 to $750.00 and gave the stock a "buy" rating in a research report on Thursday, May 8th. The Goldman Sachs Group upped their price target on shares of Axon Enterprise from $730.00 to $830.00 and gave the stock a "buy" rating in a research report on Wednesday, May 14th. Craig Hallum downgraded shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $652.73.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.